Annual report pursuant to Section 13 and 15(d)

16. Subsequent Events

v3.20.4
16. Subsequent Events
12 Months Ended
Dec. 31, 2020
Subsequent Events [Abstract]  
Subsequent Events
16. Subsequent Events

 

The Company performed a review of events subsequent to the balance sheet date through the date the financial statements were issued and determined that, other than the Pharmsynthez Loan Extension discussed in Note 7, Goodwill, Indefinite-Lived Intangible Assets and Other Long-Term Assets, there were no such events requiring recognition or disclosure in the financial statements.